...
机译:吸毒者治疗丙型肝炎病毒(HCV)感染的预测指标
Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA;
Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA;
Department of Medicine, Boston Medical Center, and Boston University School of Medicine, Boston, MA, USA;
Department of Medicine, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA;
Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA;
Beth Israel/Deaconess Medical Center, and Harvard Medical School, Boston, MA, USA;
Beth Israel/Deaconess Medical Center, and Harvard Medical School, Boston, MA, USA;
Lahey Clinic Medical Center, Burlington, MA, USA;
Department of Medicine, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA;
Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA|Department of Medicine, Boston Medical Center, Boston, MA, USA;
HCV; interferon; HIV; risk factors;
机译:丙型肝炎病毒(HCV)感染和HCV /人类免疫缺陷病毒合并感染的注射吸毒者的管理和治疗。
机译:丙型肝炎病毒(HCV)治疗对人免疫缺陷病毒-HCV合并感染的患者抗逆转录病毒治疗依从性的积极影响:对于注射吸毒者扩大获得HCV治疗的另一论据。
机译:伊朗德黑兰MAH-o-MEHR危害减少中心的静脉吸毒者(IDU)中的乙型肝炎病毒(HBV),丙型肝炎病毒(HCV)和人类免疫缺陷病毒(HIV)感染率
机译:丙型肝炎病毒基因型和F蛋白对注射吸毒者HCV感染结局的影响
机译:巴基斯坦吸毒者中丙型肝炎病毒感染和注射毒品使用之间的相关性
机译:在年轻的HCV感染的注射吸毒者中开始治疗丙型肝炎病毒(HCV)感染的相关兴趣因素
机译:丙型肝炎病毒(HCV)感染以及被HCV和HIV / HCV感染的注射吸毒者重新感染
机译:可用于治疗牛病毒性腹泻病毒(BVDV)感染和丙型肝炎病毒(HCV)感染的化合物,方法和组合物。